U.S. Remote Patient Monitoring Market - Industry Outlook and Forecast 2023-2028

248 pages

70 tables

86 charts

4 region

1 countries

48 company

4 segments

Purchase Options

$4200.00
$4999.00
$5999.00
$2000.00

Have a question?

Please get in touch with our team in case of any queries

+1-312-235-2040

THE U.S. REMOTE PATIENT MONITORING MARKET IS EXPECTED TO REACH USD 25.28 BILLION BY 2028 FROM USD 13.40 BILLION IN 2022, GROWING AT A CAGR OF 11.16% DURING THE FORECAST PERIOD

The U.S. Remote Patient Monitoring Market Size, Share, & Trends Analysis Report By

  • Component: Services and Devices & Software
  • Application: Cardiovascular Diseases, Respiratory Diseases, Diabetes, Musculoskeletal Diseases, and Others
  • End-User: Hospitals, Home Healthcare Settings, Ambulatory Care Settings, and Long-term Care Centers
  • Geography: United States (South, West, Midwest, and Northeast)

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

U.S. REMOTE PATIENT MONITORING MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2028)USD 25.28 Billion
Market Size (2022)USD 13.40 Billion
CAGR (2022-2028)11.16%
Base Year2022
Forecast Year2023-2028
Market SegmentsComponent, Application, End-User, and Geography
Geographic AnalysisUnited States (South, West, Midwest, and Northeast)
KEY VENDORSAMD Global Telemedicine, GE Healthcare, Koninklijke Philips, Medtronic, ResMed, Teledoc Health, and Vivify Health
Interested in this Report?

Download a Sample!

MARKET OUTLOOK

The U.S. remote patient monitoring market was valued at USD 13.40 billion in 2022 and is expected to reach USD 25.28 billion by 2028, growing at a CAGR of 11.16%. Healthcare delivery through electronic communication and telehealth has significantly changed since its inception. The advent of electronic health records (EHRs) and increased access to the internet and medical devices has enabled healthcare to move from the traditional clinical setting to the patient's home. Remote patient monitoring (RPM) is a type of telehealth in which healthcare providers monitor patients outside of traditional care using digital medical devices such as scales, blood pressure monitors, pulse oximeters, and blood glucose meters.  Data collected from these devices is sent electronically to care management providers. Automated feedback and workflows can be incorporated into data collection to flag out-of-range or critical readings. Further, the increasing prevalence of chronic diseases, technological advancements, and higher penetration of mHealth are some of the key drivers of the U.S. remote patient monitoring market growth.

During the COVID-19 public health emergency (PHE), telehealth replaced face-to-face consultations with virtual processes wherever possible, exposing patients to infected patients. Like other forms of telehealth, RPM implementations have grown and evolved rapidly throughout PHE. In addition to increasing the use of RPM for chronic illnesses, many organizations have begun acute illness surveillance and developing programs to monitor patients for COVID-19 symptoms outside hospitals. These programs aimed to reduce hospital burden and identify changes in patient conditions during increased hospital occupancy. Moreover, healthcare systems are partnering with market vendors and other key stakeholders to increase awareness of the advantages of remote patient monitoring devices, thereby contributing to U.S. remote patient monitoring market growth. Key players in the market are focused on product approval and launch to expand their product portfolio, contributing to technological advancements and catering to consumers who constantly demand these monitoring devices.

MARKET TRENDS & DRIVERS

Advances in Remote Patient Monitoring Technology
The COVID-19 pandemic has accelerated the growth of the U.S. remote patient monitoring market and has caught the attention of many medical professionals. Recently, IoT-enabled monitoring devices have added offering more functionalities to RPM. By combining AI with the Internet of Things (IoT) and RPM, healthcare organizations and practitioners can better serve their patients and provide opportunities for improved healthcare outcomes.

Increasing Demand for Wireless Patient Monitoring at Home
Over the last few years, home patient monitoring has become a standard of care among adult patients that require a long-term alternative to hospital-based care. The trend toward using a wireless patient monitoring system to monitor vital signs continues to grow. Among many benefits being brought to the healthcare service by wireless patient monitoring is the facility to escalate home care for both chronic and acute conditions. The emergence of new technologies and capabilities makes taking care of one at home possible.

Increasing Focus on Developing Software & Apps for RPM by Manufacturers
Increasing focus on developing software and apps specifically for remote patient monitoring (RPM) by manufacturers is an innovative way to improve and simplify the management of health conditions in both private and public healthcare settings. This ensures that care providers have access to accurate and secure data collected from patients tracked remotely through wearables and connected devices. Manufacturers in the U.S. remote patient monitoring market are investing in this trend by creating apps and software solutions that offer customizable and secure data-driven solutions for RPM. These solutions range from automated patient feedback protocols to machine learning algorithms that better track patient data and behavior. Manufacturers are also offering user-friendly and secure ways for care providers to access more accurate patient data and make informed decisions based on the data. This is creating a new landscape of both secure and efficient RPM services.

The Growing Use of RPM to Monitor & Improve Patient Engagement
Remote patient monitoring (RPM) uses technology to collect, transmit, and review patient-generated data outside the traditional medical care setting. It allows healthcare providers to remotely monitor patients and gain insight into their physical state without having them physically present for a physical check-up. RPM can also detect changes in a patient's condition before they become obvious to the patient and help healthcare providers provide better, more personalized, and timely care. Through RPM, healthcare providers can keep track of patients' medical conditions in real time and monitor them from a distance. It enables clinicians to identify potentially serious illnesses early and intervene with appropriate treatment. RPM can lead to better outcomes, improved patient engagement, and fewer hospitalizations. RPM also reduces healthcare costs by providing earlier treatment and better managing chronic conditions. Patients benefit from quality care while remaining in their homes with improved access to care and an enhanced overall care experience.

Miniaturization is the next big thing in RPM devices using advanced technology. Device key players are reducing the size and invasiveness of their products while cooperating with new companies to boost their share in the U.S. remote patient monitoring market.

Growing Use of Mobile Technologies & Smart Devices in RPM
Remote patient monitoring uses smartphones, tablets, and other devices to track patient health information constantly. It enables healthcare providers to track a wide range of vital signs such as heart rate, blood pressure, respiratory rate, and body temperature, allowing them to monitor patients from the comfort of their homes. With the growing use of mobile technology, remote patient monitoring can be done on the go. This improves access to care for remote populations and increases efficiency in healthcare delivery. Additionally, it enables real-time remote monitoring of those with chronic illnesses, allowing for timely intervention to prevent further health complications. Mobile technology also ensures data accuracy and consistency, critical for effective decision-making and patient care.

SEGMENTATION INSIGHTS

INSIGHTS BY COMPONENT
The U.S. remote patient monitoring market by component is segmented into services and, devices & software. In 2022, the software segment accounted for the largest share of the market. Service in the remote patient monitoring market involves using telemetric technology to monitor and collect patient health data from a remote location. This technology allows medical professionals to monitor their patient's health without requiring them to enter a physical medical facility. These services provide access to real-time patient health data, such as blood pressure, blood glucose levels, body temperature, and heart rate. In addition, telemetry technology can also be used to send alerts if an unusual change in vital signs is detected, allowing medical professionals to intervene quickly. This technology allows medical professionals to provide the best care for patients while they are away from the hospital and allows for earlier interventions when needed.

INSIGHTS BY APPLICATION
The cardiovascular diseases application segment held the largest U.S. remote patient monitoring market share in 2022, accounting for over 39%. According to the Centers for Disease Control and Prevention (CDC), approximately 11 million patients in the US suffer from cardiac dysrhythmia or arrhythmias. An increase in the prevalence of cardiovascular diseases (CVDs) is one of the factors driving the demand for cardiac monitoring devices. Remote cardiac monitoring has become the norm for patients with heart diseases, especially using implantable cardiac devices. With easy access to real-time telemetry data, cardiologists can determine if a condition represents an emergency illness and create an essentially virtual hospital. In addition, a quarter of health agencies report that RPM reduces visits and readmissions to emergency rooms. Further, the increased use of remote cardiac monitors to improve the detection of hypertension has been the focus of intense research activity in recent years. Remote cardiac monitors provide a viable solution for detecting hypertension at home without cumbersome and intrusive devices and procedures.

INSIGHTS BY END-USER
The U.S. remote patient monitoring market by end-user is segmented into hospitals, home healthcare settings, ambulatory care settings, and long-term care centers. The hospital's segment accounted for the largest share and dominated the segment. The U.S. healthcare system and hospitals plan to improve outcomes and reduce costs through remote patient monitoring (RPM) technology. Hospital settings dominate cardiac monitoring equipment and are the initial point of contact for patients with health challenges. Patients with a history of cardiac arrhythmia are typically treated in hospitals. For the monitoring of CVDs, hospitals have the most up-to-date machines and technology. Though healthcare practitioners are always looking for ways to reduce patients' time in the hospital, the COVID-19 epidemic has increased pressure on physicians to minimize contact time even more to avoid virus exposure. One method that healthcare practitioners are addressing this issue is through remote patient monitoring. By allowing doctors to monitor their patients outside the hospital or doctor's office, they can reduce patients' time in those settings without jeopardizing their health.

REGIONAL ANALYSIS

The southern region accounted for 41% of the U.S. remote patient monitoring market in 2022 and dominated the market. The use of remote patient monitoring in Texas has steadily increased over the past few years. This technology is now being implemented in healthcare organizations across the state to help monitor, manage, and provide patient care more efficiently and effectively. The emergence of remote patient monitoring technology and its steady increase in usage in Texas reflects the state's commitment to providing improved patient care. Remote patient monitoring has been instrumental in cutting costs, as it allows for fewer hospital and clinic visits, thus decreasing the likelihood of patient complications due to prolonged exposure and wait times in an unfamiliar setting.

The remote patient monitoring market in the western U.S. and states like California is fast-growing and evolving. As the nation's largest and most populous state, the opportunities for meaningful collaboration on remote care through digital health tools are virtually limitless. Remote health monitoring or telehealth is a rapidly-expanding healthcare segment, allowing clinicians, care providers, and other health professionals to connect with and monitor patient populations remotely.

COMPETITIVE LANDSCAPE

The U.S. remote patient monitoring market is in a state of intense competition. The industry includes providers of a range of products and services, from diagnosis and treatment to delivery of healthcare applications. Companies operating in this segment are continually forced to innovate and improve to gain a competitive edge. Over the past few years, the U.S. remote patient monitoring market has grown rapidly with the entry of new players and the widespread adoption of technological advances. The focus is shifting towards conquering and expanding the market share from smaller, more localized players to larger, national-scale players. This competition has led to market size, scope growth, and product diversification.

AMD Global Telemedicine, GE Healthcare, Koninklijke Philips, Medtronic, ResMed, Teledoc Health, and Vivify Health are some of the top vendors in the U.S. remote patient monitoring market, offering a wide range of RPM solutions. However, many local vendors are providing products with similar specifications at lower prices, which has resulted in a price war among vendors. Major vendors continuously compete for the leading position in the market, with occasional competition coming from other local vendors.

Frequently Asked Questions

How big is the U.S. remote patient monitoring market?

The U.S. remote patient monitoring market size was valued at USD 13.40 billion in 2022 and is expected to reach USD 25.28 billion by 2028.

What is the growth rate of the U.S. remote patient monitoring market?

The U.S. remote patient monitoring market is growing at a CAGR of 11.16% from 2022-2028.

What are the rising trends in the U.S. remote patient monitoring market?

The rising trends in the US remote patient monitoring market are advances in remote patient monitoring technology, increasing demand for wireless patient monitoring at home, the rise of virtual clinical trials, AI & IoT driving the adoption of remote patient monitoring, and telemedicine ushering new opportunities for remote monitoring.

Which region holds the most significant U.S. remote patient monitoring market share?

The south region dominated the global U.S. remote patient monitoring market share in 2022, accounting for over 41.%.

Who are the top players in the U.S. remote patient monitoring market?

AMD Global Telemedicine, GE Healthcare, Koninklijke Philips, Medtronic, ResMed, Teledoc Health, and Vivify Health are the top players in the U.S. remote patient monitoring market.

The U.S. remote patient monitoring market is expected to grow at a CAGR of approximately 11.16% from 2022 to 2028.

The following factors are likely to contribute to the growth of the U.S. remote patient monitoring market during the forecast period:

  • Increasing Focus on Developing Software & Apps for RPM by Manufacturers
  • Demographics of the Aging Population & Chronic Disorders Augmenting Continuous Monitoring Demand
  • Increasing Innovations in Wearable Technology
  • Growing Use of RPM to Monitor & Improve Patient Engagement
  • Growing Use of Mobile Technologies & Smart Devices in RPM

Base Year: 2022

Forecast Year: 2023-2028

The report considers the present scenario of the U.S. remote patient monitoring market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.

Key Company Profiles

  • AMD Global Telemedicine
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • GE Healthcare
  • Koninklijke Philips
  • Medtronic
  • ResMed
  • Teledoc Health
  • Vivify Health

Other Prominent Vendors

  • 100-Plus
    • Business Overview
    • Product Offerings
  • Abbott
  • ACL Digital
  • Altumview
  • Baxter
  • Biobeat
  • Biofourmis
  • BIOTRONIK
  • Boston Scientific
  • Cardiologs
  • Cardiomo
  • CAREMINDr
  • CareValidate
  • Datos Health
  • Dexcom
  • Drägerwerk AG
  • F.Hoffmann-La Roche
  • GrandCare Systems
  • Health Recovery Solutions
  • Hinge Health
  • Honeywell International
  • iHealth Unified Care
  • Intel
  • iRhythm Technologies
  • Limber Health
  • Masimo
  • MedM
  • Medopad
  • ModivCare
  • NIHON KOHDEN
  • OMRON
  • OSI Systems
  • OSPLabs
  • Qardio
  • Resideo Technologies
  • Senseonics
  • TeleMedCare
  • Ventricle Health
  • VitalConnect
  • Vitls
  • VivaLNK

Segmentation by Component

  • Services
  • Devices & Software

Segmentation by Application

  • Cardiovascular Diseases
  • Respiratory Diseases
  • Diabetes
  • Musculoskeletal Diseases
  • Others

Segmentation by End-User

  • Hospitals
  • Home Healthcare Settings
  • Ambulatory Care Settings
  • Long-term Care Centers

Segmentation by Region

  • South
    • Texas
    • Florida
    • Virginia
    • Oklahoma
    • New Mexico
  • West
    • California
    • Colorado
    • Nevada
    • Montana
  • Midwest
    • Michigan
    • Illinois
    • Ohio
  • Northeast
    • New York
    • Pennsylvania
    • Massachusetts

EXHIBIT 1 SEGMENTATION OF US REMOTE PATIENT MONITORING MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022

EXHIBIT 3 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2022 & 2028 (% SHARE)

EXHIBIT 4 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2022 & 2028 (% SHARE)

EXHIBIT 5 US REMOTE PATIENT MONITORING MARKET BY END-USER 2022 & 2028 (% SHARE)

EXHIBIT 6 COMPONENTS OF TELEHEALTH SERVICES

EXHIBIT 7 HEALTHCARE IOT & RPM TRANSFORMING CARE DELIVERY

EXHIBIT 8 GLOBAL REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 9 GLOBAL REMOTE PATIENT MONITORING MARKET BY GEOGRAPHY: 2022 & 2028 (% SHARE)

EXHIBIT 10 REMOTE PATIENT MONITORING MARKET SHARE: US & REST OF WORLD (% SHARE)

EXHIBIT 11 CONSUMER RESPONSE TOWARD REMOTE PATIENT MONITORING ADOPTION IN US

EXHIBIT 12 NEW CPT CODES REIMBURSE FOR REMOTE PATIENT MONITORING

EXHIBIT 13 IMPACT OF ADVANCES IN REMOTE PATIENT MONITORING TECHNOLOGY

EXHIBIT 14 IMPACT OF INCREASING DEMAND FOR WIRELESS PATIENT MONITORING AT HOME

EXHIBIT 15 IMPACT OF RISE OF VIRTUAL CLINICAL TRIALS

EXHIBIT 16 POTENTIAL FACTORS DRIVING VIRTUAL CLINICAL TRIALS IN US

EXHIBIT 17 PATIENT MONITORING EXAMPLES: OVERVIEW OF WEARABLE AND DEVICE INTEGRATION IN DCTS

EXHIBIT 18 NEW CONNECTED DEVICES POWERS CLINICAL TRIALS WITH BETTER DATA

EXHIBIT 19 IMPACT OF AI & IOT DRIVES RPM ADOPTION

EXHIBIT 20 IMPACT OF TELEMEDICINE USHERING NEW OPPORTUNITIES FOR REMOTE MONITORING

EXHIBIT 21 IMPACT OF INCREASING FOCUS ON DEVELOPING SOFTWARE & APPS FOR RPM BY MANUFACTURERS

EXHIBIT 22 IMPACT OF AGING POPULATION & CHRONIC DISORDERS AUGMENTING CONTINUOUS MONITORING DEMAND

EXHIBIT 23 PREVALENCE DATA OF CHRONIC DISEASES IN THE US

EXHIBIT 24 IMPACT OF INCREASING INNOVATIONS IN WEARABLE TECHNOLOGY

EXHIBIT 25 CONVERGENCE OF TECHNOLOGIES LEADING TO THE INDUSTRIAL REVOLUTION

EXHIBIT 26 ADVANTAGES OF USING REMOTE BIOSENSORS IN CLINICAL RESEARCH

EXHIBIT 27 IMPACT OF GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT

EXHIBIT 28 WAYS REMOTE PATIENT MONITORING IMPROVES PATIENT ENGAGEMENT

EXHIBIT 29 IMPACT OF GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES IN RPM

EXHIBIT 30 IMPACT OF REGULATORY VARIATIONS ACROSS US

EXHIBIT 31 IMPACT OF LACK OF DATA ACCURACY

EXHIBIT 32 IMPACT OF THREAT FROM HEALTHCARE FRAUDS

EXHIBIT 33 IMPACT OF ACCESSIBILITY OR CONNECTIVITY OBSTACLES WITH PATIENTS

EXHIBIT 34 US REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 35 US REMOTE PATIENT MONITORING MARKET BY COMPONENT: MARKET OPPORTUNITY OVERVIEW 2022 & 2028

EXHIBIT 36 US REMOTE PATIENT MONITORING MARKET BY APPLICATION: MARKET OPPORTUNITY OVERVIEW 2022 & 2028

EXHIBIT 37 US REMOTE PATIENT MONITORING MARKET BY END-USER: MARKET OPPORTUNITY OVERVIEW 2022 & 2028

EXHIBIT 38 FIVE FORCES ANALYSIS 2022

EXHIBIT 39 INCREMENTAL GROWTH BY COMPONENT 2022 & 2028

EXHIBIT 40 US REMOTE PATIENT MONITORING MARKET BY COMPONENT: INCREMENTAL GROWTH

EXHIBIT 41 US REMOTE PATIENT MONITORING MARKET BY COMPONENT: ABSOLUTE GROWTH

EXHIBIT 42 US SERVICES REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028

EXHIBIT 43 US SERVICES REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 44 US DEVICES & SOFTWARE REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028

EXHIBIT 45 US DEVICES & SOFTWARE REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 46 INCREMENTAL GROWTH BY APPLICATION 2022 & 2028

EXHIBIT 47 US REMOTE PATIENT MONITORING MARKET BY APPLICATION: INCREMENTAL GROWTH

EXHIBIT 48 PREVALENCE OF CHRONIC CONDITIONS AND THEIR EXPONENTIAL IMPACT ON HEALTHCARE COSTS IN US

EXHIBIT 49 US REMOTE PATIENT MONITORING MARKET BY APPLICATION: ABSOLUTE GROWTH

EXHIBIT 50 US CARDIOVASCULAR DISEASES REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028

EXHIBIT 51 US CARDIOVASCULAR DISEASES REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 52 US RESPIRATORY DISEASES REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028

EXHIBIT 53 US RESPIRATORY DISEASES REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 54 US DIABETES REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028

EXHIBIT 55 US DIABETES REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 56 US MUSCULOSKELETAL DISEASES REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028

EXHIBIT 57 US MUSCULOSKELETAL DISEASES REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 58 US OTHERS REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028

EXHIBIT 59 US OTHERS REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 60 INCREMENTAL GROWTH BY END-USER 2022 & 2028

EXHIBIT 61 US REMOTE PATIENT MONITORING MARKET BY END-USER: INCREMENTAL GROWTH

EXHIBIT 62 US REMOTE PATIENT MONITORING MARKET BY END-USER: ABSOLUTE GROWTH

EXHIBIT 63 US HOSPITALS REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028

EXHIBIT 64 US HOSPITALS REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 65 US HOME HEALTHCARE SETTINGS REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028

EXHIBIT 66 US HOME HEALTHCARE SETTINGS REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 67 US AMBULATORY CARE SETTINGS REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028

EXHIBIT 68 US AMBULATORY CARE SETTINGS REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 69 US LONG-TERM CARE CENTERS REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028

EXHIBIT 70 US LONG-TERM CARE CENTERS REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)

EXHIBIT 71 VENDORS OFFERING COMMERCIAL REMOTE PATIENT MONITORING SOLUTIONS: MARKET DOMINANCE ANALYSIS

EXHIBIT 72 VENDORS OFFERING COMMERCIAL REMOTE PATIENT MONITORING SOLUTIONS: CAPABILITIES & EXPERTISE ASSESSMENT

EXHIBIT 73 GE HEALTHCARE: TOTAL REVENUE 2020–2022 ($ BILLION)

EXHIBIT 74 GE HEALTHCARE: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)

EXHIBIT 75 KONINKLIJKE PHILIPS: TOTAL REVENUE 2020–2022 ($ BILLION)

EXHIBIT 76 KONINKLIJKE PHILIPS: R&D EXPENDITURE 2020–2022 ($ BILLION)

EXHIBIT 77 KONINKLIJKE PHILIPS: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)

EXHIBIT 78 KONINKLIJKE PHILIPS: REVENUE BY GEOGRAPHY 2022 ($ BILLION)

EXHIBIT 79 MEDTRONIC: REVENUE 2020–2022 ($ BILLION)

EXHIBIT 80 MEDTRONIC: R&D EXPENDITURE 2020–2022 ($ BILLION)

EXHIBIT 81 MEDTRONIC: REVENUE BY BUSINESS SEGMENT 2019–2021 ($ BILLION)

EXHIBIT 82 MEDTRONIC: REVENUE BY GEOGRAPHY 2022 ($ BILLION)

EXHIBIT 83 RESMED: TOTAL REVENUE 2020–2022 ($ BILLION)

EXHIBIT 84 RESMED: R&D EXPENDITURE 2020–2022 ($ BILLION)

EXHIBIT 85 TELADOC HEALTH: TOTAL REVENUE 2020–2022 ($ BILLION)

EXHIBIT 86 TELADOC HEALTH: REVENUE BY GEOGRAPHY 2020–2022 ($ BILLION)

 

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2016−2022

TABLE 3 GLOBAL REMOTE PATIENT MONITORING BY GEOGRAPHY 2022–2028 ($ BILLION)

TABLE 4 GLOBAL REMOTE PATIENT MONITORING BY GEOGRAPHY 2022–2028 (%)

TABLE 5 CHRONIC DISEASE PREVALENCE AND IMPACT ON HEALTHCARE SYSTEMS OF US & WORLD

TABLE 6 CHANGE IN HOSPITAL STAY COST IN US 2010–2020

TABLE 7 US REMOTE PATIENT MONITORING MARKET BY COMPONENT: MARKET SIZE 2022 & 2028

TABLE 8 US REMOTE PATIENT MONITORING MARKET BY APPLICATION: MARKET SIZE 2022 & 2028

TABLE 9 US REMOTE PATIENT MONITORING MARKET BY END-USER: MARKET SIZE 2022 & 2028

TABLE 10 FAST FACTS ABOUT US HOSPITALS

TABLE 11 AMD GLOBAL TELEMEDICINE: MAJOR PRODUCT OFFERINGS

TABLE 12 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 13 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS

TABLE 14 MEDTRONIC: MAJOR PRODUCT OFFERINGS

TABLE 15 RESMED: MAJOR PRODUCT OFFERINGS

TABLE 16 TELEDOC HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 17 VIVIFY HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 18 100-PLUS: MAJOR PRODUCT OFFERINGS

TABLE 19 ABBOTT: MAJOR PRODUCT OFFERINGS

TABLE 20 ACL DIGITAL: MAJOR PRODUCT OFFERINGS

TABLE 21 ALTUMVIEW: MAJOR PRODUCT OFFERINGS

TABLE 22 BAXTER: MAJOR PRODUCT OFFERINGS

TABLE 23 BIOBEAT: MAJOR PRODUCT OFFERINGS

TABLE 24 BIOFOURMIS: MAJOR PRODUCT OFFERINGS

TABLE 25 BIOTRONIK: MAJOR PRODUCT OFFERINGS

TABLE 26 BOSTON SCIENTIFIC: MAJOR PRODUCT OFFERINGS

TABLE 27 CARDIOLOGS: MAJOR PRODUCT OFFERINGS

TABLE 28 CARDIOMO: MAJOR PRODUCT OFFERINGS

TABLE 29 CAREMINDR: MAJOR PRODUCT OFFERINGS

TABLE 30 CAREVALIDATE: MAJOR PRODUCT OFFERINGS

TABLE 31 CLEARARCH: MAJOR PRODUCT OFFERINGS

TABLE 32 DATOS HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 33 DEXCOM: MAJOR PRODUCT OFFERINGS

TABLE 34 DRÄGERWERK AG: MAJOR PRODUCT OFFERINGS

TABLE 35 F. HOFFMANN-LA ROCHE.: MAJOR PRODUCT OFFERINGS

TABLE 36 GRANDCARE SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 37 HEALTH RECOVERY SOLUTIONS: MAJOR PRODUCT OFFERINGS

TABLE 38 HINGE HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 39 HONEYWELL INTERNATIONAL: MAJOR PRODUCT OFFERINGS

TABLE 40 IHEALTH UNIFIED CARE: MAJOR PRODUCT OFFERINGS

TABLE 41 INTEL: MAJOR PRODUCT OFFERINGS

TABLE 42 IRHYTHM TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 43 LIMBER HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 44 MASIMO: MAJOR PRODUCT OFFERINGS

TABLE 45 MEDM: MAJOR PRODUCT OFFERINGS

TABLE 46 MEDOPAD.: MAJOR PRODUCT OFFERINGS

TABLE 47 MODIVCARE: MAJOR PRODUCT OFFERINGS

TABLE 48 NIHON KOHDEN: MAJOR PRODUCT OFFERINGS

TABLE 49 OMRON: MAJOR PRODUCT OFFERINGS

TABLE 50 OSI SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 51 OSPLABS: MAJOR PRODUCT OFFERINGS

TABLE 52 QARDIO: MAJOR PRODUCT OFFERINGS

TABLE 53 SENSEONICS: MAJOR PRODUCT OFFERINGS

TABLE 54 TELEMEDCARE: MAJOR PRODUCT OFFERINGS

TABLE 55 VENTRICLE HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 56 VITALCONNECT: MAJOR PRODUCT OFFERINGS

TABLE 57 VITLS: MAJOR PRODUCT OFFERINGS

TABLE 58 VIVALNK: MAJOR PRODUCT OFFERINGS

TABLE 59 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2022−2028 ($ BILLION)

TABLE 60 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2022−2028 (%)

TABLE 61 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2022−2028 ($ BILLION)

TABLE 62 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2022−2028 (%)

TABLE 63 US REMOTE PATIENT MONITORING MARKET BY END-USER 2022−2028 ($ BILLION)

TABLE 64 US REMOTE PATIENT MONITORING MARKET BY END-USER 2022−2028 (%)

TABLE 65 US HOME HEALTHCARE SETTINGS REMOTE PATIENT MONITORING MARKET BY REGION 2022−2028 ($ BILLION)

TABLE 66 US HOME HEALTHCARE SETTINGS REMOTE PATIENT MONITORING MARKET BY REGION 2022−2028 (%)

TABLE 67 US HOME HEALTHCARE REMOTE PATIENT MONITORING MARKET BY COMPONENT 2022−2028 ($ BILLION)

TABLE 68 US HOME HEALTHCARE REMOTE PATIENT MONITORING MARKET BY COMPONENT 2022−2028 (%)

TABLE 69 US HOME HEALTHCARE REMOTE PATIENT MONITORING MARKET BY APPLICATION 2022−2028 ($ BILLION)

TABLE 70 US HOME HEALTHCARE REMOTE PATIENT MONITORING MARKET BY APPLICATION 2022−2028 (%)

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

 

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY COMPONENT

4.3.2 MARKET SEGMENTATION BY APPLICATION

4.3.3 MARKET SEGMENTATION BY END-USER

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

 

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

 

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

7.1 OVERVIEW

7.1.1 COMPONENT INSIGHTS

7.1.2 APPLICATION INSIGHTS

7.1.3 END-USER INSIGHTS

 

8 INTRODUCTION

8.1 BACKGROUND

8.2 REMOTE PATIENT MONITORING: OVERVIEW

8.3 REMOTE PATIENT MONITORING: GLOBAL OUTLOOK

8.3.1 GLOBAL REMOTE PATIENT MONITORING BY GEOGRAPHY

8.4 REMOTE PATIENT MONITORING: GLOBAL VS US OUTLOOK

 

9 MARKET OPPORTUNITIES & TRENDS

9.1 ADVANCES IN REMOTE PATIENT MONITORING TECHNOLOGY

9.2 INCREASING DEMAND FOR WIRELESS PATIENT MONITORING AT HOME

9.3 RISE OF VIRTUAL CLINICAL TRIALS

9.4 AI & IOT DRIVES RPM ADOPTION

9.5 TELEMEDICINE USHERING NEW OPPORTUNITIES FOR REMOTE MONITORING

 

10 MARKET GROWTH ENABLERS

10.1 INCREASING FOCUS ON DEVELOPING SOFTWARE & APPS FOR RPM BY MANUFACTURERS

10.2 AGING POPULATION & CHRONIC DISORDERS AUGMENTING CONTINUOUS MONITORING DEMAND

10.3 INCREASING INNOVATIONS IN WEARABLE TECHNOLOGY

10.4 GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT

10.5 GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES IN RPM

 

11 MARKET RESTRAINTS

11.1 REGULATORY VARIATIONS ACROSS US

11.2 LACK OF DATA ACCURACY

11.3 THREAT FROM HEALTHCARE FRAUDS

11.4 ACCESSIBILITY OR CONNECTIVITY OBSTACLES WITH PATIENTS

 

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.3 MARKET OPPORTUNITIES

12.3.1 MARKET BY COMPONENT

12.3.2 MARKET BY APPLICATION

12.3.3 MARKET BY END-USER

12.4 FIVE FORCES ANALYSIS

12.4.1 THREAT OF NEW ENTRANTS

12.4.2 BARGAINING POWER OF SUPPLIERS

12.4.3 BARGAINING POWER OF BUYERS

12.4.4 THREAT OF SUBSTITUTES

12.4.5 COMPETITIVE RIVALRY

 

13 COMPONENT

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 SERVICES

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.4 DEVICES & SOFTWARE

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

 

14 APPLICATION

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 CARDIOVASCULAR DISEASES

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.4 RESPIRATORY DISEASES

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.5 DIABETES

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.6 MUSCULOSKELETAL DISEASES

14.6.1 MARKET OVERVIEW

14.6.2 MARKET SIZE & FORECAST

14.7 OTHERS

14.7.1 MARKET OVERVIEW

14.7.2 MARKET SIZE & FORECAST

 

15 END-USER

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 HOSPITALS

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.4 HOME HEALTHCARE SETTINGS

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.5 AMBULATORY SURGICAL CENTERS

15.5.1 MARKET OVERVIEW

15.5.2 MARKET SIZE & FORECAST

15.6 LONG-TERM CARE CENTERS

15.6.1 MARKET OVERVIEW

15.6.2 MARKET SIZE & FORECAST

 

16 COMPETITIVE LANDSCAPE

16.1 COMPETITION OVERVIEW

16.1.1 VENDORS ACTIVITIES

16.2 MARKET SHARE ANALYSIS

16.2.1 AMD GLOBAL TELEMEDICINE

16.2.2 GE HEALTHCARE

16.2.3 KONINKLIJKE PHILIPS

16.2.4 MEDTRONIC

16.2.5 RESMED

16.2.6 TELADOC HEALTH

16.2.7 VIVIFY HEALTH

 

17 KEY COMPANY PROFILES

17.1 AMD GLOBAL TELEMEDICINE

17.1.1 BUSINESS OVERVIEW

17.1.2 PRODUCT OFFERINGS

17.1.3 KEY STRATEGIES

17.1.4 KEY STRENGTHS

17.1.5 KEY OPPORTUNITIES

17.2 GE HEALTHCARE

17.2.1 BUSINESS OVERVIEW

17.2.2 PRODUCT OFFERINGS

17.2.3 KEY STRATEGIES

17.2.4 KEY STRENGTHS

17.2.5 KEY OPPORTUNITIES

17.3 KONINKLIJKE PHILIPS

17.3.1 BUSINESS OVERVIEW

17.3.2 PRODUCT OFFERINGS

17.3.3 KEY STRATEGIES

17.3.4 KEY STRENGTHS

17.3.5 KEY OPPORTUNITIES

17.4 MEDTRONIC

17.4.1 BUSINESS OVERVIEW

17.4.2 PRODUCT OFFERINGS

17.4.3 KEY STRATEGIES

17.4.4 KEY STRENGTHS

17.4.5 KEY OPPORTUNITIES

17.5 RESMED

17.5.1 BUSINESS OVERVIEW

17.5.2 PRODUCT OFFERING

17.5.3 KEY STRATEGIES

17.5.4 KEY STRENGTHS

17.5.5 KEY OPPORTUNITIES

17.6 TELADOC HEALTH

17.6.1 BUSINESS OVERVIEW

17.6.2 PRODUCT OFFERINGS

17.6.3 KEY STRATEGIES

17.6.4 KEY STRENGTHS

17.6.5 KEY OPPORTUNITIES

17.7 VIVIFY HEALTH

17.7.1 BUSINESS OVERVIEW

17.7.2 PRODUCT OFFERING

17.7.3 KEY STRATEGIES

17.7.4 KEY STRENGTHS

17.7.5 KEY OPPORTUNITIES

 

18 OTHER PROMINENT VENDORS

18.1 100-PLUS

18.1.1 BUSINESS OVERVIEW

18.1.2 PRODUCT OFFERINGS

18.2 ABBOTT

18.2.1 BUSINESS OVERVIEW

18.2.2 PRODUCT OFFERINGS

18.3 ACL DIGITAL

18.3.1 BUSINESS OVERVIEW

18.3.2 PRODUCT OFFERINGS

18.4 ALTUMVIEW

18.4.1 BUSINESS OVERVIEW

18.4.2 PRODUCT OFFERINGS

18.5 BAXTER

18.5.1 BUSINESS OVERVIEW

18.5.2 PRODUCT OFFERINGS

18.6 BIOBEAT

18.6.1 BUSINESS OVERVIEW

18.6.2 PRODUCT OFFERINGS

18.7 BIOFOURMIS

18.7.1 BUSINESS OVERVIEW

18.7.2 PRODUCT OFFERING

18.8 BIOTRONIK

18.8.1 BUSINESS OVERVIEW

18.8.2 PRODUCT OFFERING

18.9 BOSTON SCIENTIFIC

18.9.1 BUSINESS OVERVIEW

18.9.2 PRODUCT OFFERINGS

18.10 CARDIOLOGS

18.10.1 BUSINESS OVERVIEW

18.10.2 PRODUCT OFFERINGS

18.11 CARDIOMO

18.11.1 BUSINESS OVERVIEW

18.11.2 PRODUCT OFFERINGS

18.12 CAREMINDR

18.12.1 BUSINESS OVERVIEW

18.12.2 PRODUCT OFFERING

18.13 CAREVALIDATE

18.13.1 BUSINESS OVERVIEW

18.13.2 PRODUCT OFFERINGS

18.14 CLEARARCH

18.14.1 BUSINESS OVERVIEW

18.14.2 PRODUCT OFFERINGS

18.15 DATOS HEALTH

18.15.1 BUSINESS OVERVIEW

18.15.2 PRODUCT OFFERINGS

18.16 DEXCOM

18.16.1 BUSINESS OVERVIEW

18.16.2 PRODUCT OFFERING

18.17 DRÄGERWERK AG

18.17.1 BUSINESS OVERVIEW

18.17.2 PRODUCT OFFERINGS

18.18 F. HOFFMANN-LA ROCHE

18.18.1 BUSINESS OVERVIEW

18.18.2 PRODUCT OFFERINGS

18.19 GRANDCARE SYSTEMS

18.19.1 BUSINESS OVERVIEW

18.19.2 PRODUCT OFFERINGS

18.20 HEALTH RECOVERY SOLUTIONS

18.20.1 BUSINESS OVERVIEW

18.20.2 PRODUCT OFFERINGS

18.21 HINGE HEALTH

18.21.1 BUSINESS OVERVIEW

18.21.2 PRODUCT OFFERINGS

18.22 HONEYWELL INTERNATIONAL

18.22.1 BUSINESS OVERVIEW

18.22.2 PRODUCT OFFERINGS

18.23 IHEALTH UNIFIED CARE

18.23.1 BUSINESS OVERVIEW

18.23.2 PRODUCT OFFERINGS

18.24 INTEL

18.24.1 BUSINESS OVERVIEW

18.24.2 PRODUCT OFFERING

18.25 IRHYTHM TECHNOLOGIES

18.25.1 BUSINESS OVERVIEW

18.25.2 PRODUCT OFFERING

18.26 LIMBER HEALTH

18.26.1 BUSINESS OVERVIEW

18.26.2 PRODUCT OFFERINGS

18.27 MASIMO

18.27.1 BUSINESS OVERVIEW

18.27.2 PRODUCT OFFERINGS

18.28 MEDM

18.28.1 BUSINESS OVERVIEW

18.28.2 PRODUCT OFFERING

18.29 MEDOPAD

18.29.1 BUSINESS OVERVIEW

18.29.2 PRODUCT OFFERINGS

18.30 MODIVCARE

18.30.1 BUSINESS OVERVIEW

18.30.2 PRODUCT OFFERINGS

18.31 NIHON KOHDEN

18.31.1 BUSINESS OVERVIEW

18.31.2 PRODUCT OFFERINGS

18.32 OMRON

18.32.1 BUSINESS OVERVIEW

18.32.2 PRODUCT OFFERINGS

18.33 OSI SYSTEMS

18.33.1 BUSINESS OVERVIEW

18.33.2 PRODUCT OFFERINGS

18.34 OSPLABS

18.34.1 BUSINESS OVERVIEW

18.34.2 PRODUCT OFFERINGS

18.35 QARDIO

18.35.1 BUSINESS OVERVIEW

18.35.2 PRODUCT OFFERING

18.36 SENSEONICS

18.36.1 BUSINESS OVERVIEW

18.36.2 PRODUCT OFFERINGS

18.37 TELEMEDCARE

18.37.1 BUSINESS OVERVIEW

18.37.2 PRODUCT OFFERINGS

18.38 VENTRICLE HEALTH

18.38.1 BUSINESS OVERVIEW

18.38.2 PRODUCT OFFERINGS

18.39 VITALCONNECT

18.39.1 PRODUCT OFFERINGS

18.40 VITLS

18.40.1 BUSINESS OVERVIEW

18.40.2 PRODUCT OFFERINGS

18.41 VIVALNK

18.41.1 BUSINESS OVERVIEW

18.41.2 PRODUCT OFFERINGS

 

19 REPORT SUMMARY

19.1 KEY TAKEAWAYS

19.2 STRATEGIC RECOMMENDATIONS

 

20 QUANTITATIVE SUMMARY

20.1 MARKET BY COMPONENT

20.2 MARKET BY APPLICATION

20.3 MARKET BY END-USER

20.4 HOME HEALTHCARE SETTINGS BY REGION

20.5 HOME HEALTHCARE SETTINGS BY COMPONENT

20.6 HOME HEALTHCARE SETTINGS BY APPLICATION

21 APPENDIX

21.1 ABBREVIATIONS

Select a license type that suits your business needs

Single User Licence

$4200.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$4999.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$5999.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

How big is the U.S. remote patient monitoring market?

The U.S. remote patient monitoring market size was valued at USD 13.40 billion in 2022 and is expected to reach USD 25.28 billion by 2028.

What is the growth rate of the U.S. remote patient monitoring market?

The U.S. remote patient monitoring market is growing at a CAGR of 11.16% from 2022-2028.

What are the rising trends in the U.S. remote patient monitoring market?

The rising trends in the US remote patient monitoring market are advances in remote patient monitoring technology, increasing demand for wireless patient monitoring at home, the rise of virtual clinical trials, AI & IoT driving the adoption of remote patient monitoring, and telemedicine ushering new opportunities for remote monitoring.

Which region holds the most significant U.S. remote patient monitoring market share?

The south region dominated the global U.S. remote patient monitoring market share in 2022, accounting for over 41.%.

Who are the top players in the U.S. remote patient monitoring market?

AMD Global Telemedicine, GE Healthcare, Koninklijke Philips, Medtronic, ResMed, Teledoc Health, and Vivify Health are the top players in the U.S. remote patient monitoring market.